본문 바로가기
KERD
논문KCI 등재

Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Despite advances in cancer therapy, the clinical outcome of patients with gastric cancer remains poor, largely due to tumor heterogeneity. Thus, finding a hidden vulnerability of clinically refractory subtypes of gastric cancer is crucial. Here, we report that chemoresistant gastric cancer cells rely heavily on endocytosis, facilitated by caveolin-1, for survival. caveolin-1 was highly upregulated in the most malignant stem-like/EMT/mesenchymal (SEM)-type gastric cancer cells, allowing caveolin-1-mediated endocytosis and utilization of extracellular proteins via lysosomal degradation. Downregulation of caveolin-1 alone was sufficient to induce cell death in SEM-type gastric cancer cells, emphasizing its importance as a survival mechanism. Consistently, chloroquine, a lysosomal inhibitor, successfully blocked caveolin-1-mediated endocytosis, leading to the marked suppression of tumor growth in chemorefractory gastric cancer cells in vitro, including patient-derived organoids, and in vivo. Together, our findings suggest that caveolin-1-mediated endocytosis is a key metabolic pathway for gastric cancer survival and a potential therapeutic target.

Abstract

Despite advances in cancer therapy, the clinical outcome of patients with gastric cancer remains poor, largely due to tumor heterogeneity. Thus, finding a hidden vulnerability of clinically refractory subtypes of gastric cancer is crucial. Here, we report that chemoresistant gastric cancer cells rely heavily on endocytosis, facilitated by caveolin-1, for survival. caveolin-1 was highly upregulated in the most malignant stem-like/EMT/mesenchymal (SEM)-type gastric cancer cells, allowing caveolin-1-mediated endocytosis and utilization of extracellular proteins via lysosomal degradation. Downregulation of caveolin-1 alone was sufficient to induce cell death in SEM-type gastric cancer cells, emphasizing its importance as a survival mechanism. Consistently, chloroquine, a lysosomal inhibitor, successfully blocked caveolin-1-mediated endocytosis, leading to the marked suppression of tumor growth in chemorefractory gastric cancer cells in vitro, including patient-derived organoids, and in vivo. Together, our findings suggest that caveolin-1-mediated endocytosis is a key metabolic pathway for gastric cancer survival and a potential therapeutic target.

참고문헌 (55)

  1. Cheong, J. H., "Predictive test for chemotherapy response in resectable gastric cancer : a multi-cohort, retrospective analysis", Lancet. Oncol, 19, pp.629~638 (2018)
  2. Lei, Z., "Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil", Gastroenterology, 145, pp.554~565 (2013)
  3. Kumari, S., "Endocytosis unplugged : multiple ways to enter the cell", Cell Res, 20, pp.256~275 (2010)
  4. Fennelly, C., "Lysosomal biology in cancer", Methods Mol. Biol, 1594, pp.293~308 (2017)
  5. Bonam, S. R., "Lysosomes as a therapeutic target", Nat. Rev. Drug Discov, 18, pp.923~948 (2019)
  6. Piao, S., "Targeting the lysosome in cancer", Ann. N. Y. Acad. Sci, 1371, pp.45~54 (2016)
  7. Gyparaki, M. T., "Lysosome : the cell’s ‘suicidal bag’ as a promising cancer target", Trends Mol. Med, 20, pp.239~241 (2014)
  8. Commisso, C., "Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells", Nature, 497, pp.633~637 (2013)
  9. Kim, S. M., "Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways", J. Clin. Invest, 126, pp.4088~4102 (2016)
  10. Palm, W., "The utilization of extracellular proteins as nutrients is suppressed by mTORC1", Cell, 162, pp.259~270 (2015)
  11. Kiss, A. L., "Endocytosis via caveolae : alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J", Cell. Mol. Med, 13, pp.1228~1237 (2009)
  12. Chidlow, J. H. Jr, "Caveolae, caveolins, and cavins : complex control of cellular signalling and inflammation", Cardiovasc. Res, 86, pp.219~225 (2010)
  13. Suzuoki, M., "Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma", Br. J. Cancer, 87, pp.1140~1144 (2002)
  14. Huang, C., "A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis", Cancer Res, 72, pp.655~665 (2012)
  15. Ho, C. C., "Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation", Am. J. Pathol, 161, pp.1647~1656 (2002)
  16. Zhan, P., "Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas", Oncol. Rep, 27, pp.1072~1078 (2012)
  17. Yoo, S. H., "Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung", Lung Cancer, 42, pp.195~202 (2003)
  18. Ho, C. C., "Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy", Lung Cancer, 59, pp.105~110 (2008)
  19. Wang, S., "Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated metabolic reprogramming", Cell Death Dis, 11, pp.450~ (2020)
  20. Burgermeister, E., "Caveats of caveolin-1 in cancer progression", Cancer Lett, 268, pp.187~201 (2008)
  21. Nwosu, Z. C., "Caveolin-1 in the regulation of cell metabolism : a cancer perspective", Mol. Cancer, 15, pp.71~ (2016)
  22. Bender, F. C., "Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity", Cancer Res, 60, pp.5870~5878 (2000)
  23. Wiechen, K., "Caveolin-1 Is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene", Am. J. Pathol, 159, pp.1635~1643 (2001)
  24. Sloan, E. K., "Caveolin-1 inhibits breast cancer growth and metastasis", Oncogene, 23, pp.7893~7897 (2004)
  25. Delvecchio, R., "Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models", Viruses (2016)[DOI]
  26. Hu, T. Y., "Insights from nanomedicine into chloroquine efficacy against COVID-19", Nat. Nanotechnol, 15, pp.247~249 (2020)
  27. Kim, E. L., "Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells", Neuro Oncol, 12, pp.389~400 (2010)
  28. Yang, S., "Pancreatic cancers require autophagy for tumor growth", Genes Dev, 25, pp.717~729 (2011)
  29. Maclean, K. H., "Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis", J. Clin. Invest, 118, pp.79~88 (2008)
  30. Sotelo, J., "Adding chloroquine to conventional treatment for glioblastoma multiforme : a randomized, double-blind, placebo-controlled trial", Ann. Intern. Med, 144, pp.337~343 (2006)
  31. Rosenfeld, M. R., "A phase I", II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme, 2014, pp.10, 1359~1368
  32. Mahalingam, D., "Combined autophagy and HDAC inhibition : a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors", Autophagy, 10, pp.1403~1414 (2014)
  33. Bartfeld, S., "In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection", Gastroenterology, 148, pp.126~136 (2015)
  34. Kim, J., "Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity", npj Precis. Oncol, 6, pp.9~ (2022)
  35. Wang, L., "The role of CD44 and cancer stem cells", Methods Mol Biol, 1692, pp.31~42 (2018)
  36. Lee, J., "Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT", Gastroenterology, 155, pp.799~814 (2018)
  37. Simón, L., "Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer", Cancer Metastasis Rev, 39, pp.435~453 (2020)
  38. Shi, Y., "Critical role of CAV1", caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy, 2015, pp.11, 769~784
  39. Luzio, J. P., "Lysosomes : fusion and function", Nat. Rev. Mol. Cell Biol, 8, pp.622~632 (2007)
  40. Rennick, J. J., "Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics", Nat. Nanotechnol, 16, pp.266~276 (2021)
  41. Kamphorst, J. J., "Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein", Cancer Res, 75, pp.544~553 (2015)
  42. Maekawa, M., "Sequential breakdown of 3-phosphorylated phosphoinositides is essential for the completion of macropinocytosis", Proc. National Acad. Sci. USA, 111, pp.E978~E987 (2014)
  43. Su, H., "Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis", Cancer Cell, 39, pp.678~693 (2021)
  44. Kang, X., "LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target", Oncogene, 40, pp.3422~3433 (2021)
  45. Liu, H., "Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma : A preliminary study", Oncotarget, 7, pp.43894~43906 (2016)
  46. Scheel, C., "Cancer stem cells and epithelial-mesenchymal transition : concepts and molecular links", Semin. Cancer Biol, 22, pp.396~403 (2012)
  47. Zhang, Y., "Targeting the Wnt", β-catenin signaling pathway in cancer, 2020, pp.13, 165~
  48. Huang, L., "Epithelial-mesenchymal transition in gastric cancer", Am. J. Transl. Res, 7, pp.2141~2158 (2015)
  49. Gao, Q., "Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis", Oncol. Lett, 9, pp.2381~2387 (2015)
  50. Thomas, S., "Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer", Cancer Res, 71, pp.832~841 (2011)
  51. Chatterjee, M., "Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy", Cancer Res, 77, pp.5925~5937 (2017)
  52. Zhao, Y., "Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial", BMC Cancer, 18, pp.1019~ (2018)
  53. Pavlova, N. N., "The emerging hallmarks of cancer metabolism", Cell Metab, 23, pp.27~47 (2016)
  54. Yim, W. W. -Y., "Lysosome biology in autophagy", Cell Discov, 6, pp.6~ (2020)
  55. Sandri, M., "Protein breakdown in muscle wasting : Role of autophagy-lysosome and ubiquitin-proteasome", Int. J. Biochem. Cell Biol, 45, pp.2121~2129 (2013)

관련 논문AI추천

Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cellsCheong Jae-Ho, Choi Yoon Young, Huh Yong-Min, Hyung Woo Jin, Jang Eunji, Kim Hyeseon, Kim Hyunki, Kim Jungeun, Lee Jae Eun, Lim Joo Yeon, Noh Sung Hoon, Park Jungmin, Shin Min-Kyue, Shin Youngmin, Son Hye-Young, Suh Jin-Suck, Sung Ji-Yong생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms강진호, 김열홍, 김인선, 박경화, 박종국, 박주희, 서재홍, 이혜진, 조욱현대한암학회 · Cancer Research and Treatment2016 · 제48권 제2호Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma양소미, 이정신, 이지민, Ji-Yeon Lee, Jueun Kim생화학분자생물학회 · BMB Reports2023 · 제56권 제11호Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity김현석, 한균희, Gino Kwon, Hakhyun Kim, Jooyoung Lee, Joo-Youn Lee, Minseo Kim, Sang Bum Kim, Sejin Oh, Seonghwi Choi, Seungbin Cha, Yeojin Sung, Yunji Lee생화학분자생물학회 · BMB Reports2022 · 제55권 제12호Functional significance of cholesterol metabolism in cancer: from threat to treatmentLi Jialin, Liu Jiang, Shi Si, Wang Wei, Xiao Mingming, Xu Hang, Xu Jin, Yu Xianjun, Zhang Bo, Zhao Yingjun생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Gastrointestinal cancer organoids—applications in basic and translational cancer researchSeidlitz Therese, Stange Daniel E.생화학분자생물학회 · Experimental and Molecular Medicine2021 · 제53권

이 간행물의 다른 논문 (225건)